<DOC>
	<DOC>NCT00092118</DOC>
	<brief_summary>The purpose of this study is to determine the effect of an approved medication on the symptoms of perennial allergic rhinitis (an inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year), in patients who have a history of perennial allergic rhinitis.</brief_summary>
	<brief_title>The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Nonsmoker with a 2year documented history of perennial allergic (symptoms that persist throughout the year) rhinitis symptoms and positive allergy testing Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>